Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Shawna L. Weis"'
Publikováno v:
Translational Medicine ISBN: 9781003124542
Translational Medicine
Translational Medicine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9be29e839ea92a54e3411c7bfe21eb89
https://doi.org/10.1201/9781003124542-19
https://doi.org/10.1201/9781003124542-19
Autor:
Mark Paciga, Emmanuel Sampene, Jingyu Yu, Patricia Keegan, Rashmi Rawat, Hong Zhao, Jennie T. Chang, Hongshan Li, Deborah Schmiel, Runyan Jin, Richard Pazdur, Whitney S. Helms, Marc R. Theoret, Kun He, Shawna L. Weis, Meredith K. Chuk, Liang Zhao
Publikováno v:
Clinical Cancer Research. 23:5666-5670
On September 4, 2014, the FDA approved pembrolizumab (KEYTRUDA; Merck Sharp & Dohme Corp.) with a recommended dose of 2 mg/kg every 3 weeks by intravenous infusion for the treatment of patients with unresectable or metastatic melanoma who have progre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ba6ff85f01dfec65ef77be9fcc96883
https://doi.org/10.1158/1078-0432.ccr-16-0663
https://doi.org/10.1158/1078-0432.ccr-16-0663
Autor:
Xianhua Cao, Marc R. Theoret, Meredith Libeg, Liang Zhao, Whitney S. Helms, Kun He, Laurie Graham, Richard Pazdur, Meredith K. Chuk, Hongshan Li, Joel T. Welch, Hong Zhao, Maitreyee Hazarika, Rajeshwari Sridhara, Alexander H. Putman, Sirisha Mushti, Shawna L. Weis, Patricia Keegan
Publikováno v:
Clinical Cancer Research. 23:3484-3488
On December 22, 2014, the FDA granted accelerated approval to nivolumab (OPDIVO; Bristol-Myers Squibb) for the treatment of patients with unresectable or metastatic melanoma and disease progression following ipilimumab and, if BRAF V600 mutation posi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e7bc35b67a158b74e0bb24405e795d5
https://doi.org/10.1158/1078-0432.ccr-16-0712
https://doi.org/10.1158/1078-0432.ccr-16-0712
Autor:
Hoberman, Alan M., Maki, Kazushige, Mikashima, Fumito, Naota, Misaki, Wange, Ronald L., Lansita, Janice A., Weis, Shawna L.
Publikováno v:
International Journal of Toxicology (Sage); Dec2023, Vol. 42 Issue 6, p467-479, 13p
Publikováno v:
Health & Medicine Week; 10/6/2023, p1182-1182, 1p
Publikováno v:
Medical Letter on the CDC & FDA; 6/3/2024, p1709-1709, 1p
Autor:
Joy A. Cavagnaro, Mary Ellen Cosenza
Translational Medicine: Optimizing Preclinical Safety Evaluation of Biopharmaceuticals provides scientists responsible for the translation of novel biopharmaceuticals into clinical trials with a better understanding of how to navigate the obstacles t